1. Home
  2. BBW vs DAWN Comparison

BBW vs DAWN Comparison

Compare BBW & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$53.94

Market Cap

696.0M

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$9.43

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
DAWN
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
696.0M
624.8M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
BBW
DAWN
Price
$53.94
$9.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$67.71
$26.56
AVG Volume (30 Days)
529.6K
3.2M
Earning Date
12-04-2025
11-04-2025
Dividend Yield
1.62%
N/A
EPS Growth
15.02
N/A
EPS
4.36
N/A
Revenue
$525,767,000.00
$133,672,000.00
Revenue This Year
$8.36
$15.51
Revenue Next Year
$3.62
$49.99
P/E Ratio
$12.45
N/A
Revenue Growth
6.17
31.11
52 Week Low
$32.55
$5.64
52 Week High
$75.85
$13.53

Technical Indicators

Market Signals
Indicator
BBW
DAWN
Relative Strength Index (RSI) 55.24 56.50
Support Level $45.50 $8.13
Resistance Level $54.89 $10.47
Average True Range (ATR) 2.75 0.62
MACD 0.41 0.08
Stochastic Oscillator 71.96 53.50

Price Performance

Historical Comparison
BBW
DAWN

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: